Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 331 followers
Latest posts
Last updated 32 minutes ago
Senate HELP Committee chair pitches proposals for FDA reform
32 minutes ago
In his report, Senator Bill Cassidy suggested a slate of changes to...
Gut-focused Rasayana ingests gastrointestinal candidate in $36M licensing deal
about 2 hours ago
In a deal with Theriva Biologics potentially worth as much as $36...
Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug
about 2 hours ago
Only a couple of months ago, Sensei Biotherapeutics was laying off staff...
Novartis finds natural partner in macrocycle biotech, inking $1.7B+ cardio deal
about 2 hours ago
Unnatural Products is proving to be a natural at securing partnerships, this...
FDA accepts filing for Moderna flu vaccine after swift rethink
about 3 hours ago
The FDA has accepted Moderna’s revised influenza vaccine filing days after controversially...
Preclinical eye disease biotech sets sights on $17M NYSE IPO
about 3 hours ago
EIR Biopharma is hoping to bring in $17.1 million from an IPO...
Korsana crosses into crowded Alzheimer's field with $175M and anti-amyloid antibody
about 6 hours ago
A new entrant in the race to shepherd antibodies for Alzheimer’s disease...
Lilly pays CSL $100M upfront for IL-6 antibody that flunked a phase 3 organ transplant study
about 7 hours ago
Eli Lilly is paying $100 million upfront for the right to develop...
Danaher buys patient monitoring specialist Masimo in $9.9 billion deal
about 9 hours ago
Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9...
Immunology CRO RoukenBio pens pact with AVS Bio for more predictable antibody development
about 21 hours ago
Preclinical CRO RoukenBio has inked a partnership with Connecticut-based biologics supplier AVS...
Boehringer axes inhaled gene therapy after viewing cystic fibrosis data
about 23 hours ago
Boehringer Ingelheim is discarding an inhaled gene therapy designed to treat cystic...
Cell therapy company hopes to end Tokyo biotech IPO drought with $92M offering
1 day ago
Japan-based cell therapy company Innovacell is planning to end a drought of...